litlas
Log inCreate account

Alice B. Gottlieb

Active 1978–2025

209
Papers
39,880
Citations
110
h-index
204
i10-index

Citations

Citations per year for Alice B. Gottlieb1964: 1 citations1979: 5 citations1980: 11 citations1981: 11 citations1982: 14 citations1983: 2 citations1984: 9 citations1985: 7 citations1986: 3 citations1987: 4 citations1988: 15 citations1989: 14 citations1990: 41 citations1991: 43 citations1992: 42 citations1993: 33 citations1994: 27 citations1995: 38 citations1996: 31 citations1997: 46 citations1998: 45 citations1999: 73 citations2000: 43 citations2001: 51 citations2002: 80 citations2003: 112 citations2004: 106 citations2005: 182 citations2006: 189 citations2007: 228 citations2008: 199 citations2009: 268 citations2010: 210 citations2011: 287 citations2012: 226 citations2013: 242 citations2014: 213 citations2015: 238 citations2016: 257 citations2017: 390 citations2018: 432 citations2019: 1,206 citations2020: 1,469 citations2021: 1,390 citations2022: 1,049 citations2023: 907 citations2024: 1,345 citations2025: 585 citations2026: 8 citations1965–1978: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,041 citing papers, 23.5% of this breakdownUnited Kingdom: 989 citing papers, 7.7% of this breakdownGermany: 915 citing papers, 7.1% of this breakdownChina: 785 citing papers, 6.1% of this breakdownCanada: 780 citing papers, 6% of this breakdownItaly: 717 citing papers, 5.5% of this breakdownFrance: 499 citing papers, 3.9% of this breakdownSpain: 421 citing papers, 3.3% of this breakdownNetherlands: 405 citing papers, 3.1% of this breakdownJapan: 361 citing papers, 2.8% of this breakdownSwitzerland: 353 citing papers, 2.7% of this breakdownDenmark: 284 citing papers, 2.2% of this breakdown
0%23.5%Other 26.1%

Institutions

Fields

  • Medicine42.9%
  • Immunology and Microbiology40%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Neuroscience3.8%
  • Pharmacology, Toxicology and Pharmaceutics1.7%
  • Dentistry0.6%
  • Other1.9%

Topics

  • Psoriasis: Treatment and Pathogenesis17.4%
  • Spondyloarthritis Studies and Treatments9.2%
  • Dermatology and Skin Diseases8%
  • Rheumatoid Arthritis Research and Therapies5.3%
  • Hidradenitis Suppurativa and Treatments2.4%
  • Autoimmune and Inflammatory Disorders Research2.3%
  • Other55.4%

Coauthors

All papers

Open in search
  1. Psoriasis

    Authors: Jacqueline Greb, Ari M. Goldminz, James T. Elder, Mark Lebwohl, Dafna D. Gladman, Jashin J. Wu, Nehal N. Mehta, A.Y. Finlay, Alice B. Gottlieb - Nature Reviews Disease Primers 2016 cited by 897

  2. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

    Authors: Alan Menter, Bruce Strober, Daniel H. Kaplan, Darío Kivelevitch, Elizabeth Farley Prater, Benjamin K. Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena Rupani, Michael Siegel, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2019 cited by 924

  3. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

    Authors: Alexa B. Kimball, Gregor B. E. Jemec, Afsáneh Alavi, Z. Reguiaï, Alice B. Gottlieb, Falk G. Bechara, C. Paul, Evangelos J. Giamarellos Bourboulis, A. Villani, Andreas Schwinn, Franziska Ruëff, Larisha Pillay Ramaya, Adam Reich, Inês Lobo, Rodney Sinclair, Thierry Passeron, Antonio Martorell, Pedro Mendes‐Bastos, Georgios Kokolakis, Pierre‐André Bécherel, Magdalena B. Wozniak, Angela Llobet Martinez, Xiaoling Wei, Lorenz Uhlmann, Anna Passera, Deborah Keefe, Ruvie Martin, Clarice Field, Li Chen, Marc Vandemeulebroecke, Shoba Ravichandran, Elisa Muscianisi - The Lancet 2023 cited by 302

  4. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

    Authors: Farzad Alinaghi, Monika Calov, Lars Erik Kristensen, Dafna D. Gladman, Laura C. Coates, D. Jullien, Alice B. Gottlieb, Paolo Gisondi, Jashin J. Wu, Jacob P. Thyssen, Alexander Egeberg - Journal of the American Academy of Dermatology 2018 cited by 652

  5. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

    Authors: Alexa B. Kimball, Martin M. Okun, David Williams, Alice B. Gottlieb, Kim Papp, Christos C. Zouboulis, April W. Armstrong, Francisco A. Kerdel, Michael H. Gold, Seth Forman, Neil J. Korman, Evangelos J. Giamarellos‐Bourboulis, Jeffrey Crowley, Charles Lynde, Z. Reguiaï, Errol-Prospero Prens, Eihab Alwawi, Nael M. Mostafa, Brett Pinsky, Murali Sundaram, Yihua Gu, Dawn M. Carlson, Gregor B. E. Jemec - New England Journal of Medicine 2016 cited by 777

  6. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

    Authors: Craig A. Elmets, Craig L. Leonardi, Dawn Marie R. Davis, Joel M. Gelfand, Jason Lichten, Nehal N. Mehta, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Darío Kivelevitch, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Henry W. Lim, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2019 cited by 486

  7. Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial

    Authors: Philip J. Mease, Proton Rahman, Alice B. Gottlieb, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie L. Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang, Désirée van der Heijde, Iain B. McInnes - The Lancet 2020 cited by 344

  8. Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

    Authors: Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily Wong, Reena Rupani, Darío Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2020 cited by 329

  9. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

    Authors: Joseph F. Merola, Robert Landewé, Iain B. McInnes, Philip J. Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D. Gladman, Laure Gossec, Alice B. Gottlieb, Diamant Thaçi, Richard B. Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates - The Lancet 2022 cited by 158

  10. NF-κB: An essential transcription factor in psoriasis

    Authors: Ari M. Goldminz, Shiu-chung Au, N. Kim, Alice B. Gottlieb, Paul F. Lizzul - Journal of Dermatological Science 2012 cited by 357

  11. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies

    Authors: Alan Menter, Joel M. Gelfand, Cody Connor, April W. Armstrong, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Darío Kivelevitch, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Robert S. Rahimi, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Elliot B. Tapper, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2020 cited by 331

  12. Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials

    Authors: Alexa B. Kimball, Gregor B. E. Jemec, Christopher J. Sayed, Joslyn S. Kirby, Errol P. Prens, John R Ingram, Amit Garg, Alice B. Gottlieb, Jacek C. Szepietowski, Falk G. Bechara, Evangelos J. Giamarellos‐Bourboulis, Hideki Fujita, Robert Rolleri, Paulatsya Joshi, Pratiksha Dokhe, Edward Muller, Luke F. Peterson, Cynthia Madden, Muhammad Bari, Christos C. Zouboulis - The Lancet 2024 cited by 164

  13. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

    Authors: Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jennifer Kwan‐Morley, Janice Lin, Paula Marchetta, Philip J. Mease, Joseph F. Merola, Julie Miner, Christopher T. Ritchlin, Bernadette C. Siaton, Benjamin J. Smith, Abby S. Van Voorhees, A. Helena Jonsson, Amit Shah, Nancy Sullivan, Marat Turgunbaev, Laura C. Coates, Alice B. Gottlieb, Marina Magrey, W. Benjamin Nowell, Ana‐Maria Orbai, Soumya M. Reddy, José U. Scher, Evan Siegel, Michael Siegel, Jessica A. Walsh, Amy S. Turner, James Reston - Arthritis & Rheumatology 2018 cited by 481

  14. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

    Authors: David Rosmarin, Amit G. Pandya, Mark Lebwohl, Pearl E. Grimes, Iltefat Hamzavi, Alice B. Gottlieb, Kathleen Butler, Fiona Kuo, Kang Sun, Tao Ji, Michael Howell, John E. Harris - The Lancet 2020 cited by 253

  15. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Iain B. McInnes, Philip J. Mease, Bruce Kirkham, Arthur Kavanaugh, Christopher T Ritchlin, Proton Rahman, Désirée van der Heijde, R. Landewé, Philip G. Conaghan, Alice B. Gottlieb, Hanno B. Richards, Luminita Pricop, Gregory Ligozio, Manmath Patekar, Shephard Mpofu - The Lancet 2015 cited by 850

  16. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

    Authors: Ali Alikhan, Christopher J. Sayed, Afsáneh Alavi, Raed Alhusayen, Alain Brassard, Craig N. Burkhart, Karen Crowell, Daniel B. Eisen, Alice B. Gottlieb, Iltefat Hamzavi, Paul G. Hazen, Tara Jaleel, Alexa B. Kimball, Joslyn S. Kirby, Michelle A. Lowes, Robert G. Micheletti, Angela P. Miller, Haley B. Naik, Dennis P. Orgill, Yves Poulin - Journal of the American Academy of Dermatology 2019 cited by 376

  17. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

    Authors: Iain B. McInnes, Akihiko Asahina, Laura C. Coates, Robert Landewé, Joseph F. Merola, Christopher T Ritchlin, Yoshiya Tanaka, Laure Gossec, Alice B. Gottlieb, Richard B. Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Philip J. Mease - The Lancet 2022 cited by 157

  18. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

    Authors: Iain B. McInnes, Frank Behrens, Philip J. Mease, Arthur Kavanaugh, Christopher T. Ritchlin, Peter Nash, Jordi Gratacós, Philippe Goupille, Т. В. Коротаева, Alice B. Gottlieb, Ruvie Martin, Kevin Ding, Pascale Pellet, Shephard Mpofu, Luminita Pricop - The Lancet 2020 cited by 282

  19. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

    Authors: Stephen K. Tyring, Alice B. Gottlieb, Kim Papp, Ken Gordon, Craig L. Leonardi, Andrea Wang, Deepa Lalla, Michael Woolley, Angelika Jahreis, Ralph Zitnik, David Cella, Ranga Krishnan - The Lancet 2005 cited by 1,069

  20. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    Authors: Iain B. McInnes, Arthur Kavanaugh, Alice B. Gottlieb, L. Puig, Proton Rahman, Christopher T. Ritchlin, Carrie Brodmerkel, Shu Li, Yuhua Wang, Alan M. Mendelsohn, Mittie K. Doyle - The Lancet 2013 cited by 798

  21. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

    Authors: Kim Papp, Alan Menter, Mai Abe, Boni E. Elewski, Steven R. Feldman, Alice B. Gottlieb, Richard G. Langley, Thomas A. Luger, Diamant Thaçi, M. Buonanno, Pankaj Gupta, James Proulx, Shu-Ping Lan, Robert Wołk, the OPT Pivotal 1 and OPT Pivotal 2 investigators - British Journal of Dermatology 2015 cited by 322

  22. A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

    Authors: Kim Papp, Kristian Reich, C. Paul, Andrew Blauvelt, Wojciech Baran, Chantal Bolduc, D. Toth, Richard G. Langley, Jennifer Clay Cather, Alice B. Gottlieb, Diamant Thaçi, James G. Krueger, Chris B. Russell, C.E. Milmont, Jing Li, Paul Klekotka, Greg Kricorian, Ajay Nirula - British Journal of Dermatology 2016 cited by 459

  23. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

    Authors: Andrew Blauvelt, Kim Papp, Alice B. Gottlieb, Abel Jarell, Kristian Reich, Catherine Maari, Kenneth B. Gordon, Laura K. Ferris, Richard G. Langley, Yayoi Tada, Renata Gontijo Lima, Hany Elmaraghy, Gaia Gallo, L. Renda, S‐M. Park, Russel Burge, Jerry Bagel, the IXORA‐R Study Group, Ronald Vender, Mark Lomaga, Isabelle Delorme, Chih-ho Hong, Richard L. Langley, Lorne Albrecht, Lyn Guenther, Catherine Maari, Kim Papp, Kamal Ohson, Kirk Barber, Charles Lynde, Aditya Gupta, Leslie Rosoph, Jean‐Sébastien Gauthier, Melinda Gooderham, Norman Wasel, Mani Raman, Marni Wiseman, David Greenstein, Abel Jarell, C. A. L. Moon, Lani Clark, S. Jazayeri, Michael Bukhalo, Angela Moore, Tiffani K. Hamilton, Aron Gewirtzman, Lydie Hazan, Jeffrey Crowley, Craig Teller, Matthew Zirwas, Stacy Smith, Mark Lee, Stephen K. Tyring, Patricia Lee, Sunil Dhawan, Craig L. Leonardi, Amarilis Perez‐De Jesus, Wendy McFalda, Ellen Frankel, Paul S. Yamauchi, Scott Fretzin, Rocco Serrao, Todd Schlesinger, Scott Gottlieb, Peter Jenkin, Rola Gharib, Steven A. Davis, Navid Nami, Zoe Diana Draelos, Lloyd Godwin, Cindy E. Owen, Megan N. Landis, William Abramovits, Samuel Sanchez‐Rivera, Abby Van Voorhees, David Fivenson, Francisco A. Kerdel, Seth Forman, Jeffrey S. Weinberg, José González-Chávez, Brent Boyce, Linda Stein‐Gold, Charles P. Hudson, Constance Brown, James Coggi, Christina Feser, Rion Forconi, Sandra Johnson, Mark McCune, Lawrence Green, Vandana Madkan, Dana Maxwell Shipp, Kenneth B. Gordon, Jill Waibel, Oscar Soto‐Raices, Jennifer Cather, Scott Miller, John P. Scott, Douglas Young, Jessica Kaffenberger and 42 more - British Journal of Dermatology 2019 cited by 172

  24. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

    Authors: Peter Nash, Bruce Kirkham, Masato Okada, Proton Rahman, Benard Combe, Gerd‐Ruediger Burmester, David Adams, Lisa Kerr, Chin Lee, Catherine L Shuler, Mark C. Genovese, Khalid Ahmed, Jeffrey Alper, N Barkham, Ralph E. Bennett, Francisco J. Blanco, Ricardo Blanco Alonso, Howard Blumstein, Michael S. Brooks, Gerd‐Rüdiger Burmester, Patricia Cagnoli, Paul H. Caldron, Alain Cantagrel, Der‐Yuan Chen, Melvin Churchill, Christine E. Codding, Benard Combe, Peter M.G. Deane, José Del Giudice, Atul Deodhar, Rajat K. Dhar, Eva Dokoupilová, Rita M. Egan, Andrea Everding, E. Galíndez, Mark C. Genovese, David H. Goddard, Alice B. Gottlieb, Philippe Goupille, Robert Griffin, Ramesh C. Gupta, Stephen Hall, Kalpita Hatti, Mary P. Howell, Yu‐Huei Huang, Ramina Jajoo, Namieta M. Janssen, Uta Kiltz, Alan Kivitz, Steven J. Klein, Mariusz Korkosz, Roshan Kotha, Joel M. Kremer, C Lue, José Luís Marenco de la Fuente, Helena Marzo‐Ortega, Jordi Gratacós Masmitja, Philip J. Mease, Pier Luigi Meroni, Eric C. Mueller, Anupama Nandagudi, Peter Nash, Antonio Fernández‐Nebro, C. Michael Neuwelt, Ana‐Maria Orbai, Meera R. Oza, Deborah L. Parks, Debendra Pattanaik, Maria Rell‐Bakalarska, David Rosmarin, Euthalia Roussou, Anna I. Rychlewska-Hanczewksa, David Sikes, Michael T. Stack, Prashanth Sunkureddi, Hasan Tahir, Diamant Thaçi, Tsen‐Fang Tsai, Anthony Turkiewicz, L. Unger, Raúl Veiga Cabello, Ulf Wagner, Cheng-Chung Wei, Alvin F. Wells, Peter Youssef, Agnieszka Zielińska - The Lancet 2017 cited by 405